Biotech is set for a geopolitical stress test
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
Biotech is set for a geopolitical stress test

Tech

Reuters
15 January, 2022, 12:30 pm
Last modified: 15 January, 2022, 01:02 pm

Related News

  • Make money first. Geopolitics can wait
  • Food biotechnology often becomes a political issue, rather than a policy issue
  • First Biotechnology Olympiad in Bangladesh held at JU
  • Farming Future Bangladesh hosts programme to take agri biotechnology forward
  • China-US rivalry will define geopolitics in our time

Biotech is set for a geopolitical stress test

Chinese entrepreneurs who moved abroad are coming home to find favourable government policies and ample funding awaiting

Reuters
15 January, 2022, 12:30 pm
Last modified: 15 January, 2022, 01:02 pm
A medical worker prepares to administer a dose of a coronavirus disease (Covid-19) vaccine to a woman at a vaccination site, during a government-organised visit, following the coronavirus disease (Covid-19) outbreak, in Shanghai, China, 19 January, 2021. PHOTO: REUTERS/Aly Song
A medical worker prepares to administer a dose of a coronavirus disease (Covid-19) vaccine to a woman at a vaccination site, during a government-organised visit, following the coronavirus disease (Covid-19) outbreak, in Shanghai, China, 19 January, 2021. PHOTO: REUTERS/Aly Song

Diseases have no borders, but biotechnology companies do. The sector has been immune to US-China tensions so far, but political risks are building.

The industry is entering a golden age in the People's Republic. Chinese entrepreneurs who moved abroad are coming home to find favourable government policies and ample funding awaiting. Rising mRNA technology star Suzhou Abogen Biosciences, led by a former Moderna scientist, raised over $1 billion last year alone from backers like SoftBank's Vision Fund and Temasek. Consulting firm ChinaBio reckons investments into Chinese healthcare hit $38 billion in 2021, up by a third from the previous year.

International partnerships have buoyed rising stars like $27 billion BeiGene. Founded in China over a decade ago, the group boasts three listings in Shanghai, Hong Kong and New York, and three global headquarters; it operates in over 20 countries. It unveiled an up-to-$1 billion agreement with Novartis for its innovative cancer treatment in late December. Of the 500-plus pharmaceutical and biotech collaborations in China in 2021, over 60% were cross-border, according to November data from ChinaBio.

It's a pleasant contrast to the dramatic financial decoupling underway in China's technology sector, prompted by diplomatic spats over accounting oversight, national security and other issues.

Markets are worried Chinese biotech's exception won't last. A media report that the industry might be targeted by US sanctions triggered a huge selloff in December. Contract drugmaker Wuxi BioLogics, which generated over 50% of its first-half revenue in North America, shed over $10 billion in market value in a single day; BeiGene's Shanghai stock tumbled 16% on their debut.

Nothing has come of the rumours so far, but the sector is vulnerable. Companies that don't allow American regulators to inspect their audit work for three years can be kicked off New York bourses, putting BeiGene's Wall Street ticker at risk. In December, Beijing updated its list of sectors where foreign investment is banned or restricted, and left gene diagnostics and therapeutic technologies on it. That forces companies developing promising treatments like US-listed Legend Biotech to rely on complex tenuous workarounds. A geopolitical stress test looks imminent.

Top News / World+Biz / China

Biotechnology / geopolitics / Chinese Technology / US-China Tensions

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A man stands in front of collapsed buildings following an earthquake in Kahramanmaras, Turkey February 6, 2023. Ihlas News Agency (IHA) via REUTERS ATTENTION EDITORS - THIS PICTURE WAS PROVIDED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. TURKEY OUT. NO COMMERCIAL OR EDITORIAL SALES IN TURKEY.
    Deaths exceed 2,600 as catastrophic quakes ravage Turkey, Syria
  • 30% cos see double-digit growth even in hard times
    30% cos see double-digit growth even in hard times
  • Govt borrowing from commercial banks surges
    Govt borrowing from commercial banks surges

MOST VIEWED

  • Monitors displaying the stock index prices and Japanese yen exchange rate against the US dollar are seen after the New Year ceremony marking the opening of trading in 2022 at the Tokyo Stock Exchange (TSE), amid the coronavirus disease (Covid-19) pandemic, in Tokyo, Japan 4 January, 2022. PHOTO: REUTERS/Issei Kato
    Proposed data protection act to hurt FDI: Diplomats
  • Illustration: TBS
    10 jobs most likely to be replaced by AI
  • Illustration: TBS
    Preparing for the future of AI in the job market: How Bangladesh can thrive in a tech-driven world
  • Photo: Bloomberg
    Mapping the world, one centimetre at a time
  • Photo: Collected
    Astronomers discover Milky Way's most-distant stars
  • Photo: Collected
    ChatGPT makes the first move with subscription model in an ensuing AI race

Related News

  • Make money first. Geopolitics can wait
  • Food biotechnology often becomes a political issue, rather than a policy issue
  • First Biotechnology Olympiad in Bangladesh held at JU
  • Farming Future Bangladesh hosts programme to take agri biotechnology forward
  • China-US rivalry will define geopolitics in our time

Features

Photo: Collected

Get your partner a lovely present this Valentine's Day

17h | Brands
Pottery Wheel Craft Kit: A creative outlet for little hands

Pottery Wheel Craft Kit: A creative outlet for little hands

17h | Brands
Say it with Colours

Say it with Colours

1d | Mode
Photo: Courtesy

From 'Made in Bangladesh' to 'Designed in Bangladesh'

1d | Panorama

More Videos from TBS

Who will survive? Adani or Hindenburg?

Who will survive? Adani or Hindenburg?

8h | TBS Stories
James Gunn’s 8-10-year plan for the DC Universe

James Gunn’s 8-10-year plan for the DC Universe

8h | TBS Entertainment
LC issues lead to severe shortage of surgical equipment

LC issues lead to severe shortage of surgical equipment

11h | TBS Insight
Stage plays are going on in the digital age

Stage plays are going on in the digital age

16h | TBS Stories

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

3
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

4
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

5
Photo: Collected
Startups

ShopUp secures $30m debt financing to boost expansion, supply chain

6
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net